- For Patients
- Introduction to the Marshall Protocol
- Length of the MP
- Immunopathology
- Managing immunopathology
- Food and drink
- Light restriction
- Vitamin D metabolite calculator - get feedback on vitamin D results
- Therapeutic probe - best method for determining MP suitability
- Starting the Marshall Protocol
- Resources for patients
- Marshall Protocol summary
- Palliative vs. curative treatments
- Patient interviews on Bacteriality
- Non-MP treatments
- Glossary
- The Protocol
- Marshall Protocol summary
- Publications and presentations
- Science behind immunopathology
- Science behind olmesartan (Benicar)
- Safety of olmesartan
- Resources for physicians
- Vitamin D metabolite calculator - get feedback on vitamin D results
- Therapeutic probe - best method for determining MP suitability
- Physicians' concerns about the MP
- Notice for emergency medical personnel
- The Pathogenesis
- Publications and presentations
- Science behind Marshall Pathogenesis
- Microbes in the human body
- Successive infection and variability in disease
- Autoimmune theory of disease
- Science behind vitamin D
- Metabolism of vitamin D and the VDR
- Th1 Spectrum Disorder - how chronic inflammatory diseases are related
- Transmission of bacteria and onset of chronic disease
- Evolutionary perspective on disease
- Incidence and prevalence of disease
- Evidence that chronic disease is caused by pathogens
- Diseases
- Foundation
- Related Sites
Presentation
| Presenter(s) | Date | Conference | Title | Location |
|---|---|---|---|---|
| Marshall TG | 2016 September | Predictive, Preventive and Personalized Medicine | Immune Disease and the Microbiome: Healthcare in response to New Knowledge | Moscow, Russia |
| Marshall TG | 2016 April | 10th Congress on Autoimmunity | What More is there to Discover about Vitamin-D | Leipzig, Germany |
| Marshall TG | 2015 September | EPMA World Congress | Is there a role for a Tin-Foil hat in PPPM? | University of Bonn |
| Lindseth IA | 2012 May | 8th International Congress on Autoimmunity | Treatment of chronic fatigue syndrome as an immunological disorder | Granada, Spain |
| Goetze-Pelka R | 2011 November | Autoimmunity Congress Asia | Psychiatric and neurologic comorbidities as systemic dysfunctions | Singapore |
| Marshall TG | 2011 May | NeuroTalk 2011 | The human microbiome is the mechanism fueling neurodegenerative disorders | Dalian, China |
| Marshall TG | 2010 May | 7th International Congress on Autoimmunity | Olmesartan overcomes antibiotic resistance, inducing recovery from advanced autoimmune disease | Ljubljana, Slovenia |
| Blaney G | 2010 May | 7th International Congress on Autoimmunity | Olmesartan medoxomil & treatment of autoimmune disease | Ljubljana, Slovenia |
| Proal A | 2010 May | 7th International Congress on Autoimmunity | Metagenomic symbiosis between bacterial and viral pathogens in autoimmune disease | Ljubljana, Slovenia |
playground/present.txt · Last modified: 06.14.2017 by sallieq
© 2015, Autoimmunity Research Foundation. All Rights Reserved.